Shelly Peyton to Neoplasms
This is a "connection" page, showing publications Shelly Peyton has written about Neoplasms.
Connection Strength
1.412
-
Pritchard JR, Lee MJ, Peyton SR. Materials-driven approaches to understand extrinsic drug resistance in cancer. Soft Matter. 2022 May 11; 18(18):3465-3472.
Score: 0.367
-
Bittner KR, Jim?nez JM, Peyton SR. Vascularized Biomaterials to Study Cancer Metastasis. Adv Healthc Mater. 2020 04; 9(8):e1901459.
Score: 0.313
-
Brooks EA, Galarza S, Gencoglu MF, Cornelison RC, Munson JM, Peyton SR. Applicability of drug response metrics for cancer studies using biomaterials. Philos Trans R Soc Lond B Biol Sci. 2019 08 19; 374(1779):20180226.
Score: 0.301
-
Peyton SR, Gencoglu MF, Galarza S, Schwartz AD. Biomaterials in Mechano-oncology: Means to Tune Materials to Study Cancer. Adv Exp Med Biol. 2018; 1092:253-287.
Score: 0.272
-
Adler FR, Anderson ARA, Bhushan A, Bogdan P, Bravo-Cordero JJ, Brock A, Chen Y, Cukierman E, DelGiorno KE, Denis GV, Ferrall-Fairbanks MC, Gartner ZJ, Germain RN, Gordon DM, Hunter G, Jolly MK, Karacosta LG, Mythreye K, Katira P, Kulkarni RP, Kutys ML, Lander AD, Laughney AM, Levine H, Lou E, Lowenstein PR, Masters KS, Pe'er D, Peyton SR, Platt MO, Purvis JE, Quon G, Richer JK, Riddle NC, Rodriguez A, Snyder JC, Lee Szeto G, Tomlin CJ, Yanai I, Zervantonakis IK, Dueck H. Modeling collective cell behavior in cancer: Perspectives from an interdisciplinary conversation. Cell Syst. 2023 04 19; 14(4):252-257.
Score: 0.098
-
Yoshii T, Geng Y, Peyton S, Mercurio AM, Rotello VM. Biochemical and biomechanical drivers of cancer cell metastasis, drug response and nanomedicine. Drug Discov Today. 2016 09; 21(9):1489-1494.
Score: 0.061